- Home
- MTEX vs EVAX Comparison
MTEX vs EVAX Comparison
Compare MTEX & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEX
- EVAX
- Stock Information
- Founded
- MTEX 1993
- EVAX 2008
- Country
- MTEX United States
- EVAX Denmark
- Employees
- MTEX N/A
- EVAX N/A
- Industry
- MTEX Medicinal Chemicals and Botanical Products
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MTEX Health Care
- EVAX Health Care
- Exchange
- MTEX Nasdaq
- EVAX Nasdaq
- Market Cap
- MTEX 15.8M
- EVAX 17.8M
- IPO Year
- MTEX 1999
- EVAX 2021
- Fundamental
- Price
- MTEX $7.80
- EVAX $2.94
- Analyst Decision
- MTEX
- EVAX Strong Buy
- Analyst Count
- MTEX 0
- EVAX 2
- Target Price
- MTEX N/A
- EVAX $10.00
- AVG Volume (30 Days)
- MTEX 10.4K
- EVAX 89.3K
- Earning Date
- MTEX 11-11-2025
- EVAX 10-30-2025
- Dividend Yield
- MTEX N/A
- EVAX N/A
- EPS Growth
- MTEX N/A
- EVAX N/A
- EPS
- MTEX N/A
- EVAX N/A
- Revenue
- MTEX $112,975,000.00
- EVAX $3,176,000.00
- Revenue This Year
- MTEX N/A
- EVAX N/A
- Revenue Next Year
- MTEX N/A
- EVAX N/A
- P/E Ratio
- MTEX N/A
- EVAX N/A
- Revenue Growth
- MTEX N/A
- EVAX 1042.45
- 52 Week Low
- MTEX $7.05
- EVAX $1.20
- 52 Week High
- MTEX $16.49
- EVAX $17.20
- Technical
- Relative Strength Index (RSI)
- MTEX 41.05
- EVAX 52.59
- Support Level
- MTEX $8.21
- EVAX $2.71
- Resistance Level
- MTEX $9.80
- EVAX $3.04
- Average True Range (ATR)
- MTEX 0.74
- EVAX 0.19
- MACD
- MTEX -0.14
- EVAX -0.02
- Stochastic Oscillator
- MTEX 0.00
- EVAX 57.53
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.